Blastic plasmacytoid dendritic cell neoplasm: Genomics mark epigenetic dysregulation as a primary therapeutic target

M.R. Sapienza, F. Abate, F. Melle, S. Orecchioni, F. Fuligni, M. Etebari, V. Tabanelli, M.A. Laginestra, A. Pileri, G. Motta, M. Rossi, C. Agostinelli, E. Sabattini, N. Pimpinelli, M. Truni, B. Falini, L. Cerroni, G. Talarico, R. Piccioni, S. AmenteV. Indio, G. Tarantino, F. Brundu, M. Paulli, E. Berti, F. Facchetti, G.I. Dellino, F. Bertolini, C. Tripodo, R. Rabadan, S.A. Pileri

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Blastic plasmacytoid dendritic cell neoplasm: Genomics mark epigenetic dysregulation as a primary therapeutic target'. Together they form a unique fingerprint.

Medicine & Life Sciences